U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559201) titled 'Theranostic Applications of Radionuclides in Prostate Cancer' on April 23.
Brief Summary: The objective of the study is to construct a noninvasive approach ACP3 targeted PET/CT to detect tumor lesions in patients with prostate cancer and to compare with PSMA/FDG PET/CT.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer (Diagnosis)
Intervention:
DIAGNOSTIC_TEST: standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT
Each subject receives a single intravenous injection of standard-of-care imaging radiopharmaceutical (PSMA/FDG) and ACP3, and undergoes PET/CT imaging within the specified time.
Recrui...